Overview

Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
This protocol will compare topical paromomycin to standard intralesional (IL) antimony (Sb) to placebo for L braziliensis in Bolivia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Fundacion Nacional de Dermatologia
Treatments:
Paromomycin
Pentamidine